vs

Side-by-side financial comparison of T1 Energy Inc. (TE) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

T1 Energy Inc. is the larger business by last-quarter revenue ($210.5M vs $142.0M, roughly 1.5× Oncology Institute, Inc.). Oncology Institute, Inc. runs the higher net margin — -5.3% vs -62.0%, a 56.7% gap on every dollar of revenue. T1 Energy Inc. produced more free cash flow last quarter ($55.0M vs $2.2M).

Sony Energy Devices Corporation , is a Japanese multinational company specializing in a variety of areas in the energy industry, and is a wholly owned subsidiary and part of the Devices Group of Sony. The company was established in February 1975 in Fukushima, Japan.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

TE vs TOI — Head-to-Head

Bigger by revenue
TE
TE
1.5× larger
TE
$210.5M
$142.0M
TOI
Higher net margin
TOI
TOI
56.7% more per $
TOI
-5.3%
-62.0%
TE
More free cash flow
TE
TE
$52.8M more FCF
TE
$55.0M
$2.2M
TOI

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
TE
TE
TOI
TOI
Revenue
$210.5M
$142.0M
Net Profit
$-130.6M
$-7.5M
Gross Margin
10.0%
Operating Margin
-45.0%
-4.9%
Net Margin
-62.0%
-5.3%
Revenue YoY
41.6%
Net Profit YoY
-375.2%
43.0%
EPS (diluted)
$-0.87
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TE
TE
TOI
TOI
Q4 25
$142.0M
Q3 25
$210.5M
$136.6M
Q2 25
$132.8M
$119.8M
Q1 25
$53.5M
$104.4M
Q4 24
$100.3M
Q3 24
$0
$99.9M
Q2 24
$0
$98.6M
Q1 24
$0
$94.7M
Net Profit
TE
TE
TOI
TOI
Q4 25
$-7.5M
Q3 25
$-130.6M
$-16.5M
Q2 25
$-31.9M
$-17.0M
Q1 25
$-16.2M
$-19.6M
Q4 24
$-13.2M
Q3 24
$-27.5M
$-16.1M
Q2 24
$-27.0M
$-15.5M
Q1 24
$-28.5M
$-19.9M
Gross Margin
TE
TE
TOI
TOI
Q4 25
Q3 25
10.0%
Q2 25
24.7%
Q1 25
33.3%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
TE
TE
TOI
TOI
Q4 25
-4.9%
Q3 25
-45.0%
-5.9%
Q2 25
-22.0%
-9.4%
Q1 25
-44.2%
-9.5%
Q4 24
-11.9%
Q3 24
-13.9%
Q2 24
-16.6%
Q1 24
-19.0%
Net Margin
TE
TE
TOI
TOI
Q4 25
-5.3%
Q3 25
-62.0%
-12.1%
Q2 25
-24.0%
-14.2%
Q1 25
-30.4%
-18.8%
Q4 24
-13.1%
Q3 24
-16.1%
Q2 24
-15.7%
Q1 24
-21.0%
EPS (diluted)
TE
TE
TOI
TOI
Q4 25
$-0.04
Q3 25
$-0.87
$-0.14
Q2 25
$-0.21
$-0.15
Q1 25
$-0.11
$-0.21
Q4 24
$-0.14
Q3 24
$-0.20
$-0.18
Q2 24
$-0.19
$-0.17
Q1 24
$-0.20
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TE
TE
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$34.1M
Total DebtLower is stronger
$547.3M
Stockholders' EquityBook value
$96.9M
$-15.7M
Total Assets
$1.4B
$164.7M
Debt / EquityLower = less leverage
5.65×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TE
TE
TOI
TOI
Q4 25
Q3 25
$34.1M
Q2 25
$8.5M
Q1 25
$48.9M
Q4 24
Q3 24
$181.9M
Q2 24
$219.6M
$9.9M
Q1 24
$249.9M
$29.8M
Total Debt
TE
TE
TOI
TOI
Q4 25
Q3 25
$547.3M
Q2 25
$591.2M
Q1 25
$603.2M
Q4 24
Q3 24
Q2 24
Q1 24
$602.3M
Stockholders' Equity
TE
TE
TOI
TOI
Q4 25
$-15.7M
Q3 25
$96.9M
$-12.3M
Q2 25
$183.9M
$-9.0M
Q1 25
$201.9M
$5.1M
Q4 24
$3.6M
Q3 24
$538.7M
$15.5M
Q2 24
$561.6M
$29.2M
Q1 24
$582.3M
$41.3M
Total Assets
TE
TE
TOI
TOI
Q4 25
$164.7M
Q3 25
$1.4B
$163.6M
Q2 25
$1.4B
$159.8M
Q1 25
$1.4B
$164.0M
Q4 24
$172.7M
Q3 24
$615.0M
$179.2M
Q2 24
$644.4M
$179.6M
Q1 24
$670.3M
$204.5M
Debt / Equity
TE
TE
TOI
TOI
Q4 25
Q3 25
5.65×
Q2 25
3.21×
Q1 25
2.99×
Q4 24
Q3 24
Q2 24
Q1 24
1.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TE
TE
TOI
TOI
Operating Cash FlowLast quarter
$63.9M
$3.2M
Free Cash FlowOCF − Capex
$55.0M
$2.2M
FCF MarginFCF / Revenue
26.1%
1.5%
Capex IntensityCapex / Revenue
4.2%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.3M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TE
TE
TOI
TOI
Q4 25
$3.2M
Q3 25
$63.9M
$-12.6M
Q2 25
$33.4M
$-10.2M
Q1 25
$-44.8M
$-5.0M
Q4 24
$4.2M
Q3 24
$-28.4M
$819.0K
Q2 24
$-28.0M
$-15.7M
Q1 24
$-16.2M
$-15.9M
Free Cash Flow
TE
TE
TOI
TOI
Q4 25
$2.2M
Q3 25
$55.0M
$-13.2M
Q2 25
$10.6M
$-11.4M
Q1 25
$-74.0M
$-5.3M
Q4 24
$2.4M
Q3 24
$-34.0M
$417.0K
Q2 24
$-35.6M
$-17.5M
Q1 24
$-37.7M
$-16.5M
FCF Margin
TE
TE
TOI
TOI
Q4 25
1.5%
Q3 25
26.1%
-9.7%
Q2 25
8.0%
-9.5%
Q1 25
-138.4%
-5.1%
Q4 24
2.4%
Q3 24
0.4%
Q2 24
-17.7%
Q1 24
-17.4%
Capex Intensity
TE
TE
TOI
TOI
Q4 25
0.7%
Q3 25
4.2%
0.4%
Q2 25
17.2%
1.0%
Q1 25
54.5%
0.3%
Q4 24
1.8%
Q3 24
0.4%
Q2 24
1.9%
Q1 24
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TE
TE

Related Party$120.1M57%
Nonrelated Party$90.4M43%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons